ipscell.com
How risky are stem cell trials for Parkinson's beginning in China? - The Niche
New human clinical trials using derivatives of pluripotent stem cells in China for Parkinson's Disease (PD) have raised expectations
Professor Paul Knoepfler, Ph.D.
